Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 19;30(14):3032.
doi: 10.3390/molecules30143032.

Design and Synthesis of Boronic Chalcones with Dual Anticancer and Anti-Inflammatory Activity

Juliana Romano Lopes  1 , Freddy Humberto Marin-Dett  1 , Rita Alexandra Machado Silva  2 , Rafael Consolin Chelucci  3 , Lucília Saraiva  2 , Maria Emília Sousa  4   5 , Leonardo Luiz Gomes Ferreira  3 , Adriano Defini Andricopulo  3 , Paula Aboud Barbugli  6 , Jean Leandro Dos Santos  1
Affiliations

Design and Synthesis of Boronic Chalcones with Dual Anticancer and Anti-Inflammatory Activity

Juliana Romano Lopes et al. Molecules. .

Abstract

Head and neck cancer (HNC) is a highly aggressive malignancy with limited treatment options and poor prognosis. Inflammation plays a critical role in HNC progression, with elevated levels of pro-inflammatory cytokines such as TNF, IL-6, IL-8, and IL-1β contributing to tumor development. In this study, a novel series of boronic chalcones was designed and synthesized as potential dual-action anticancer and anti-inflammatory agents. The most potent compounds were evaluated for their cytotoxicity against Squamous Cell Carcinoma (SCC-25), and their selectivity index (SI) was determined. Compound 5 emerged as the most promising, displaying cytotoxicity against cancer cells, with IC50 values of 17.9 µM and a favorable SI (>3). Mechanistic studies revealed that its anticancer activity was independent of p53 status, and annexin V/PI staining indicated cell death via necrosis. Interestingly, compound 5 also significantly reduced pro-inflammatory cytokine levels, as TNF and IL-6. Furthermore, drug metabolism and pharmacokinetics (DMPK) studies demonstrated that compound 5 exhibited moderate solubility and high permeability. These findings underscore the crucial role of the boronic acid moiety in enhancing both anticancer and anti-inflammatory properties.

Keywords: anti-inflammatory; boronic acid; chalcones; head and neck cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Structural modification of chalcone-core.
Scheme 1
Scheme 1
General route for the obtained compounds (1–12).
Figure 2
Figure 2
Microscopy image of chalcone 5 following 24 h of incubation with NOK-si and SCC-25 cell models at a concentration of 9.45 μM each.
Figure 3
Figure 3
Annexin V-FITC/PI analysis of chalcone 5 carried out at three different concentrations: 44.3 μM, 22.1 μM, and 9.45 μM. Q1: Early necrotic cells; Q2: Late apoptotic cells; Q3: Viable cells; Q4: Early apoptotic cells.
Figure 4
Figure 4
Evaluation of chalcone 5 in reducing levels of (A) TNF, (B) IL-6, (C) IL-8, and (D) IL-1β in LPS-stimulated THP-1 cells at two different concentrations. Control (CT) = THP-1 cells not stimulated with LPS. * p < 0.05, ** p < 0.01, ns = not significant.
See this image and copyright information in PMC

References

    1. Johnson D.E., Burtness B., Leemans C.R., Lui V.W.Y., Bauman J.E., Grandis J.R. Head and Neck Squamous Cell Carcinoma. Nat. Rev. Dis. Primers. 2020;6:92. doi: 10.1038/s41572-020-00224-3. - DOI - PMC - PubMed
    1. Wierzbicka M., Pietruszewska W., Maciejczyk A., Markowski J. Markowski, Trends in Incidence and Mortality of Head and Neck Cancer Subsites Among Elderly Patients: A Population-Based Analysis. Cancers. 2025;17:548. doi: 10.3390/cancers17030548. - DOI - PMC - PubMed
    1. The Cancer Genome Atlas Network Comprehensive Genomic Characterization of Head and Neck Squamous Cell Carcinomas. Nature. 2015;517:576–582. doi: 10.1038/nature14129. - DOI - PMC - PubMed
    1. Leemans C.R., Braakhuis B.J.M., Brakenhoff R.H. The Molecular Biology of Head and Neck Cancer. Nat. Rev. Cancer. 2011;11:9–22. doi: 10.1038/nrc2982. - DOI - PubMed
    1. Nakano Y., Kobayashi W., Sugai S., Kimura H., Yagihashil S. Expression of Tumor Necrosis Factor-α and Interleukin-6 in Oral Squamous Cell Carcinoma. Jpn J. Cancer Res. 1999;90:858–866. doi: 10.1111/j.1349-7006.1999.tb00827.x. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources